(Q35630852)

9 August 2017

1 reference

title

Medical approaches and future options in chronic active ulcerative colitis (English)

1 reference

9 August 2017

J T Siveke

1

1 reference

9 August 2017

C Folwaczny

series ordinal

2

1 reference

9 August 2017

publication date

15 January 2004

1 reference

International Journal of Colorectal Disease

9 August 2017

published in

1 reference

9 August 2017

volume

19

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

297-307

1 reference

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

9 August 2017

cites work

1 reference

12 December 2020

An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis

1 reference

12 December 2020

Methotrexate in ulcerative colitis

1 reference

12 December 2020

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

1 reference

12 December 2020

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

1 reference

12 December 2020

Antiadhesion molecule therapy in inflammatory bowel disease

1 reference

12 December 2020

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

12 December 2020

Treatment of distal colitis with local anaesthetic agents

1 reference

12 December 2020

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

1 reference

12 December 2020

6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease

1 reference

12 December 2020

Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease

1 reference

12 December 2020

Paradoxical response to heparin in 10 patients with ulcerative colitis

1 reference

12 December 2020

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study

1 reference

12 December 2020

What have we learned from the biological therapies in ulcerative colitis?

1 reference

12 December 2020

Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial

1 reference

12 December 2020

[Guidelines of the DGVS. Fulminant process. German Society of Digestive and Metabolic Diseases]

1 reference

12 December 2020

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

1 reference

12 December 2020

Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial

1 reference

12 December 2020

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin

1 reference

12 December 2020

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

1 reference

12 December 2020

Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis

1 reference

12 December 2020

Response to heparin in patients with ulcerative colitis

1 reference

12 December 2020

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

1 reference

12 December 2020

Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease

1 reference

12 December 2020

Methotrexate and ulcerative colitis: wrong drug? Wrong dose? Or wrong disease?

1 reference

12 December 2020

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial

1 reference

12 December 2020

A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis

1 reference

12 December 2020

6-thioguanine--efficacy and safety in chronic active Crohn's disease

1 reference

12 December 2020

Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents

1 reference

12 December 2020

Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis.

1 reference

12 December 2020

Lymphocyte homing and homeostasis

1 reference

12 December 2020

A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.

1 reference

12 December 2020

The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease

1 reference

12 December 2020

TPMT in the treatment of Crohn's disease with azathioprine

1 reference

12 December 2020

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis

1 reference

12 December 2020

Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study

1 reference

12 December 2020

A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis

1 reference

12 December 2020

Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial.

1 reference

12 December 2020

Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease

1 reference

12 December 2020

Methotrexate: first-line or second-line immunomodulator?

1 reference

12 December 2020

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

1 reference

12 December 2020

Monitoring azathioprine metabolite levels and thiopurine methyl transferase (TPMT) activity in children with inflammatory bowel disease

1 reference

12 December 2020

A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

1 reference

12 December 2020

Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?

1 reference

12 December 2020

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

1 reference

12 December 2020

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

1 reference

12 December 2020

Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only

1 reference

12 December 2020

Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.

1 reference

12 December 2020

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism

1 reference

12 December 2020

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

1 reference

12 December 2020

Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

1 reference

12 December 2020

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

1 reference

12 December 2020

Infliximab for refractory ulcerative colitis

1 reference

12 December 2020

Infliximab for patients with refractory ulcerative colitis

1 reference

12 December 2020

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571.

1 reference

12 December 2020

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

1 reference

12 December 2020

Tacrolimus in corticosteroid-resistant ulcerative colitis.

1 reference

12 December 2020

Review article: maintenance of remission in ulcerative colitis

1 reference

12 December 2020

Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis

1 reference

12 December 2020

Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).

1 reference

12 December 2020

Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls

1 reference

12 December 2020

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

1 reference

12 December 2020

Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial.

1 reference

12 December 2020

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

12 December 2020

Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial

1 reference

12 December 2020

Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.

1 reference

12 December 2020

[Treatment of acute a steroid-resistant ulcerative colitis with continuous venous infusion of cyclosporine].

1 reference

12 December 2020

The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients

1 reference

12 December 2020

Nicotine for colitis--the smoke has not yet cleared

1 reference

12 December 2020

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

12 December 2020

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis

1 reference

12 December 2020

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

1 reference

12 December 2020

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

1 reference

12 December 2020

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.

1 reference

12 December 2020

Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease

1 reference

12 December 2020

Natalizumab for active Crohn's disease

1 reference

12 December 2020

Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial

1 reference

12 December 2020

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

1 reference

12 December 2020

Budesonide versus prednisolone retention enemas in active distal ulcerative colitis

1 reference

12 December 2020

Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis

1 reference

12 December 2020

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

1 reference

12 December 2020

Pharmacokinetic considerations in the treatment of inflammatory bowel disease

1 reference

12 December 2020

Outcome of ulcerative colitis after treatment with transdermal nicotine

1 reference

12 December 2020

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Intravenous cyclosporin in ulcerative colitis: a five-year experience

1 reference

12 December 2020

Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis

1 reference

12 December 2020

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease

1 reference

12 December 2020

Heparin therapy for ulcerative colitis

1 reference

12 December 2020

Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease.

1 reference

12 December 2020

Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine

1 reference

12 December 2020

Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease

1 reference

12 December 2020

Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity

1 reference

12 December 2020

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

12 December 2020

[Coagulation system and inflammatory bowel disease: therapeutic and pathophysiologic implications]

1 reference

12 December 2020

Transdermal nicotine as maintenance therapy for ulcerative colitis

1 reference

12 December 2020

Infliximab in severe steroid-refractory ulcerative colitis: a pilot study.

1 reference

12 December 2020

Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders

1 reference

12 December 2020

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

1 reference

12 December 2020

Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine

1 reference

12 December 2020

Low-dose oral methotrexate in refractory inflammatory bowel disease

1 reference

12 December 2020

10.1007/S00384-003-0569-X

Identifiers

DOI

1 reference

9 August 2017

1 reference